Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Change in Account Payables (2016 - 2025)

Healthstream (HSTM) has disclosed Change in Account Payables for 16 consecutive years, with -$48000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Change in Account Payables rose 92.42% to -$48000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $405000.0, a 36.02% decrease, with the full-year FY2025 number at $405000.0, down 36.02% from a year prior.
  • Change in Account Payables was -$48000.0 for Q4 2025 at Healthstream, down from $819000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $1.9 million in Q1 2022 to a low of -$2.5 million in Q2 2021.
  • A 5-year average of -$160750.0 and a median of -$166000.0 in 2021 define the central range for Change in Account Payables.
  • Peak YoY movement for Change in Account Payables: skyrocketed 715.41% in 2022, then tumbled 1289.16% in 2023.
  • Healthstream's Change in Account Payables stood at -$166000.0 in 2021, then changed by 0.0% to -$166000.0 in 2022, then crashed by 1289.16% to -$2.3 million in 2023, then soared by 72.55% to -$633000.0 in 2024, then surged by 92.42% to -$48000.0 in 2025.
  • Per Business Quant, the three most recent readings for HSTM's Change in Account Payables are -$48000.0 (Q4 2025), $819000.0 (Q3 2025), and -$791000.0 (Q2 2025).